Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
April-2026 Volume 57 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2026 Volume 57 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.pdf
    • Supplementary_Data2.pdf
Article Open Access

DUSP26: Unveiling a critical molecular mediator and therapeutic target in developmental dysplasia of the hip‑associated secondary osteoarthritis

  • Authors:
    • Enbo Wang
    • Haixiang Zhang
    • Dechao Wu
    • Sadik Ali
    • Xianglu Ji
  • View Affiliations / Copyright

    Affiliations: Department of Pediatric Orthopedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China, Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China
    Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
  • Article Number: 105
    |
    Published online on: February 26, 2026
       https://doi.org/10.3892/ijmm.2026.5776
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

Secondary osteoarthritis, a degenerative joint disease, is often precipitated by well‑characterized etiological factors, with developmental dysplasia of the hip (DDH) emerging as a leading contributor. Despite its clinical importance, the intricate molecular and cellular cascades triggered by the biomechanical perturbations associated with DDH remain poorly understood. In the present study, a swaddling‑induced rat model of DDH was successfully developed, which recapitulated key pathological features including acetabular labral tears and cartilage degeneration. Through comprehensive mRNA‑sequencing analysis of acetabular cartilage samples from rats with DDH, a notable upregulation of dual‑specificity phosphatase 26 (DUSP26) was identified, a protein with previously unreported roles in joint homeostasis. Subsequently, in an in vitro inflammatory microenvironment induced by interleukin (IL)‑1β, adenovirus‑mediated overexpression of DUSP26 demonstrated marked chondroprotective effects. Specifically, this intervention led to a significant increase in the expression of type II collagen, a hallmark of healthy chondrocytes, while concurrently reducing the levels of catabolic markers such as type I collagen, TNF‑α and IL‑6. Reciprocally, adenovirus‑delivered short hairpin RNA‑mediated DUSP26 silencing exacerbated cartilage degradation, validating its protective function. Employing mass spectrometry‑based proteomics combined with genetic and pharmacological approaches, the underlying mechanism was elucidated: DUSP26 overexpression exerted its chondroprotective effects by dephosphorylating and inactivating histone deacetylase (HDAC)1, HDAC2 and HDAC8, thereby maintaining chondrocyte integrity. Collectively, the findings of the present study underscore DUSP26 as a promising therapeutic target for DDH‑associated osteoarthritis, offering novel mechanistic insights and laying the groundwork for the development of targeted interventions to mitigate secondary joint degeneration.
View Figures
View References

1 

Kosuge D, Yamada N, Azegami S, Achan P and Ramachandran M: Management of developmental dysplasia of the hip in young adults: Current concepts. Bone Joint J. 95-B:732–737. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Vaquero-Picado A, Gonzalez-Moran G, Garay EG and Moraleda L: Developmental dysplasia of the hip: Update of management. EFORT Open Rev. 4:548–556. 2019. View Article : Google Scholar : PubMed/NCBI

3 

Hasegawa Y, Iwata H, Mizuno M, Genda E, Sato S and Miura T: The natural course of osteoarthritis of the hip due to subluxation or acetabular dysplasia. Arch Orthop Trauma Surg. 111:187–191. 1992. View Article : Google Scholar : PubMed/NCBI

4 

Bačenková D, Trebuňová M, Demeterová J and Živčák J: Human chondrocytes, metabolism of articular cartilage, and strategies for application to tissue engineering. Int J Mol Sci. 24:170962023. View Article : Google Scholar

5 

Harsanyi S, Zamborsky R, Krajciova L, Kokavec M and Danisovic L: Developmental dysplasia of the hip: A review of etiopathogenesis, risk factors, and genetic aspects. Medicina (Kaunas). 56:1532020. View Article : Google Scholar : PubMed/NCBI

6 

Lu K, Liao Z, Li J, Wang Y, Zhang Y, Cai L, Lu WW, Yang F, Pan H and Chen D: MSAB limits osteoarthritis development and progression through inhibition of beta-catenin-DDR2 signaling. Bioact Mater. 46:259–272. 2025.PubMed/NCBI

7 

Hong S, Derfoul A, Pereira-Mouries L and Hall DJ: A novel domain in histone deacetylase 1 and 2 mediates repression of cartilage-specific genes in human chondrocytes. FASEB J. 23:3539–3552. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Mao G, Hu S, Zhang Z, Wu P, Zhao X, Lin R, Liao W and Kang Y: Exosomal miR-95-5p regulates chondrogenesis and cartilage degradation via histone deacetylase 2/8. J Cell Mol Med. 22:5354–5366. 2018. View Article : Google Scholar : PubMed/NCBI

9 

Thompson EM and Stoker AW: A review of DUSP26: Structure, regulation and relevance in human disease. Int J Mol Sci. 22:7762021. View Article : Google Scholar : PubMed/NCBI

10 

Zhang K, Wen R, Ma W, He X, Yang Z, Liu D and Li X: Neuronal dual-specificity phosphatase 26 inhibition via reactive-oxygen-species responsive mesoporous-silica-loaded hydrogel for spinal cord injury repair. ACS Nano. 19:4942–4958. 2025. View Article : Google Scholar : PubMed/NCBI

11 

Liu C, Xu X, Sun G, Song C, Jiang S, Sun P and Tian J: Targeting DUSP26 to drive cardiac mitochondrial dynamics via FAK-ERK signaling in diabetic cardiomyopathy. Free Radic Biol Med. 225:856–870. 2024. View Article : Google Scholar : PubMed/NCBI

12 

Yu W, Imoto I, Inoue J, Onda M, Emi M and Inazawa J: A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity. Oncogene. 26:1178–1187. 2007. View Article : Google Scholar

13 

Tanuma N, Nomura M, Ikeda M, Kasugai I, Tsubaki Y, Takagaki K, Kawamura T, Yamashita Y, Sato I, Sato M, et al: Protein phosphatase Dusp26 associates with KIF3 motor and promotes N-cadherin-mediated cell-cell adhesion. Oncogene. 28:752–761. 2009. View Article : Google Scholar

14 

Kim H, Lee HJ, Oh Y, Choi SG, Hong SH, Kim HJ, Lee SY, Choi JW, Su Hwang D, Kim KS, et al: The DUSP26 phosphatase activator adenylate kinase 2 regulates FADD phosphorylation and cell growth. Nat Commun. 5:33512014. View Article : Google Scholar : PubMed/NCBI

15 

Yang CH, Yeh YJ, Wang JY, Liu YW, Chen YL, Cheng HW, Cheng CM, Chuang YJ, Yuh CH and Chen YR: NEAP/DUSP26 suppresses receptor tyrosine kinases and regulates neuronal development in zebrafish. Sci Rep. 7:52412017. View Article : Google Scholar : PubMed/NCBI

16 

Shi Y, Ma IT, Patel RH, Shang X, Chen Z, Zhao Y, Cheng J, Fan Y, Rojas Y, Barbieri E, et al: NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis. Cell Death Dis. 6:e18412015. View Article : Google Scholar : PubMed/NCBI

17 

Ye P, Liu J, Xu W, Liu D, Ding X, Le S, Zhang H, Chen S, Chen M and Xia J: Dual-specificity phosphatase 26 protects against nonalcoholic fatty liver disease in mice through transforming growth factor beta-activated kinase 1 Suppression. Hepatology. 69:1946–1964. 2019. View Article : Google Scholar :

18 

Huang F, Sheng XX and Zhang HJ: DUSP26 regulates podocyte oxidative stress and fibrosis in a mouse model with diabetic nephropathy through the mediation of ROS. Biochem Biophys Res Commun. 515:410–416. 2019. View Article : Google Scholar : PubMed/NCBI

19 

Wang E, Liu T, Li J, Edmonds EW, Zhao Q, Zhang L, Zhao X and Wang K: Does swaddling influence developmental dysplasia of the hip?: An experimental study of the traditional straight-leg swaddling model in neonatal rats. J Bone Joint Surg Am. 94:1071–1077. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar

21 

Love MI, Huber W and Anders S: Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI

22 

Moon SM, Lee SA, Han SH, Park BR, Choi MS, Kim JS, Kim SG, Kim HJ, Chun HS, Kim DK and Kim CS: Aqueous extract of Codium fragile alleviates osteoarthritis through the MAPK/NF-κB pathways in IL-1β-induced rat primary chondrocytes and a rat osteoarthritis model. Biomed Pharmacother. 97:264–270. 2018. View Article : Google Scholar

23 

Sun J, Meng D, Yu T, Li F, Zhang G, Tian X, Zhao N, Li G, Li L, Wang H, et al: N-terminal truncated carboxypeptidase E represses E-cadherin expression in lung cancer by stabilizing the Snail-HDAC complex. Am J Cancer Res. 10:925–938. 2020.PubMed/NCBI

24 

Yasunaga Y, Oshima S, Shoji T, Adachi N and Ochi M: A 30-year follow-up study of rotational acetabular osteotomy for pre- and early-stage osteoarthritis secondary to dysplasia of the hip. Bone Joint J. 106-B(Suppl): 25–31. 2024. View Article : Google Scholar : PubMed/NCBI

25 

Plečko M, Kovačić N, Grčević D, Šućur A, Vukasović Barišić A, Duvančić T, Bohaček I and Delimar D: Distinctiveness of femoral and acetabular mesenchymal stem and progenitor populations in patients with primary and secondary hip osteoarthritis due to developmental dysplasia. Int J Mol Sci. 25:51732024. View Article : Google Scholar

26 

Harris-Hayes M and Royer NK: Relationship of acetabular dysplasia and femoroacetabular impingement to hip osteoarthritis: A focused review. PM R. 3:1055–1067 e1051. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Li Z, Huang Z and Bai L: Cell interplay in osteoarthritis. Front Cell Dev Biol. 9:7204772021. View Article : Google Scholar : PubMed/NCBI

28 

Stengel KR and Hiebert SW: Class I HDACs affect DNA replication, repair, and chromatin structure: Implications for cancer therapy. Antioxid Redox Signal. 23:51–65. 2015. View Article : Google Scholar

29 

Nasu Y, Nishida K, Miyazawa S, Komiyama T, Kadota Y, Abe N, Yoshida A, Hirohata S, Ohtsuka A and Ozaki T: Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. Osteoarthritis Cartilage. 16:723–732. 2008. View Article : Google Scholar : PubMed/NCBI

30 

Zhang H, Zheng C, Chen W, Li X, Wang J, Wang T, Zhao Q, Huang H, Li Y, Yang C, et al: PP2 alleviates the progression of osteoarthritis by inhibiting Wnt/β-catenin and activating TGF-β/Smad signaling. Int Immunopharmacol. 124:1109482023. View Article : Google Scholar

31 

Miyamoto K, Ohkawara B, Ito M, Masuda A, Hirakawa A, Sakai T, Hiraiwa H, Hamada T, Ishiguro N and Ohno K: Fluoxetine ameliorates cartilage degradation in osteoarthritis by inhibiting Wnt/β-catenin signaling. PLoS One. 12:e01843882017. View Article : Google Scholar

32 

Shang X, Vasudevan SA, Yu Y, Ge N, Ludwig AD, Wesson CL, Wang K, Burlingame SM, Zhao YJ, Rao PH, et al: Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma. Oncogene. 29:4938–4946. 2010. View Article : Google Scholar : PubMed/NCBI

33 

National Research Council: Guide for the Care and Use of Laboratory Animals. 8th edition. The National Academies Press; Washington, DC: 2011

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang E, Zhang H, Wu D, Ali S and Ji X: DUSP26: Unveiling a critical molecular mediator and therapeutic target in developmental dysplasia of the hip‑associated secondary osteoarthritis. Int J Mol Med 57: 105, 2026.
APA
Wang, E., Zhang, H., Wu, D., Ali, S., & Ji, X. (2026). DUSP26: Unveiling a critical molecular mediator and therapeutic target in developmental dysplasia of the hip‑associated secondary osteoarthritis. International Journal of Molecular Medicine, 57, 105. https://doi.org/10.3892/ijmm.2026.5776
MLA
Wang, E., Zhang, H., Wu, D., Ali, S., Ji, X."DUSP26: Unveiling a critical molecular mediator and therapeutic target in developmental dysplasia of the hip‑associated secondary osteoarthritis". International Journal of Molecular Medicine 57.4 (2026): 105.
Chicago
Wang, E., Zhang, H., Wu, D., Ali, S., Ji, X."DUSP26: Unveiling a critical molecular mediator and therapeutic target in developmental dysplasia of the hip‑associated secondary osteoarthritis". International Journal of Molecular Medicine 57, no. 4 (2026): 105. https://doi.org/10.3892/ijmm.2026.5776
Copy and paste a formatted citation
x
Spandidos Publications style
Wang E, Zhang H, Wu D, Ali S and Ji X: DUSP26: Unveiling a critical molecular mediator and therapeutic target in developmental dysplasia of the hip‑associated secondary osteoarthritis. Int J Mol Med 57: 105, 2026.
APA
Wang, E., Zhang, H., Wu, D., Ali, S., & Ji, X. (2026). DUSP26: Unveiling a critical molecular mediator and therapeutic target in developmental dysplasia of the hip‑associated secondary osteoarthritis. International Journal of Molecular Medicine, 57, 105. https://doi.org/10.3892/ijmm.2026.5776
MLA
Wang, E., Zhang, H., Wu, D., Ali, S., Ji, X."DUSP26: Unveiling a critical molecular mediator and therapeutic target in developmental dysplasia of the hip‑associated secondary osteoarthritis". International Journal of Molecular Medicine 57.4 (2026): 105.
Chicago
Wang, E., Zhang, H., Wu, D., Ali, S., Ji, X."DUSP26: Unveiling a critical molecular mediator and therapeutic target in developmental dysplasia of the hip‑associated secondary osteoarthritis". International Journal of Molecular Medicine 57, no. 4 (2026): 105. https://doi.org/10.3892/ijmm.2026.5776
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team